BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/27/2018 8:15:14 AM | Browse: 1289 | Download: 1421
 |
Received |
|
2017-11-02 03:12 |
|
Peer-Review Started |
|
2017-11-02 04:22 |
|
To Make the First Decision |
|
2017-11-23 02:19 |
|
Return for Revision |
|
2017-11-27 02:40 |
|
Revised |
|
2018-01-19 23:42 |
|
Second Decision |
|
2018-02-01 08:51 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2018-02-09 03:11 |
|
Articles in Press |
|
2018-02-09 03:11 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2018-03-19 17:45 |
|
Publish the Manuscript Online |
|
2018-03-27 08:15 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article which was selected byan in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ranjit Chauhan, Shilpa Lingala, Chiranjeevi Gadiparthi, Nivedita Lahiri, Smruti R Mohanty, Jian Wu, Tomasz I Michalak and Sanjaya K Satapathy |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Sanjaya K Satapathy, FACG, FASGE, MBBS, MD, Associate Professor, Division of Transplant Surgery, Methodist University Hospital, University of Tennessee Health Sciences Center, 1211 Union Ave, Suite 340., Memphis, Tennessee 38104, United States. ssatapat@uthsc.edu |
| Key Words |
Hepatitis B virus; Liver transplantation; Reactivation; Recurrence; Prophylaxis; Antivirals; Hepatitis B immunoglobulin |
| Core Tip |
Aim of this review is to summarize the current concepts and management of hepatitis B after liver transplantation. There are no clear guidelines regarding hepatitis B therapy after transplantation. Hepatitis B immunoglobulin (HBIG) is expensive and cumbersome to administer and there is no definite time point for discontinuation of HBIG after liver transplantation. Here we summarize the indications and duration of hepatitis B immunoglobulin and nucleoside analogs. This review also addresses key molecular mechanisms and the risk factors which are associated with hepatitis B virus reactivation post liver transplantation. This review provides up-to-date information not only for the liver transplant specialists but also for the virologists and scientists working in this field. |
| Publish Date |
2018-03-27 08:15 |
| Citation |
Chauhan R, Lingala S, Gadiparthi C, Lahiri N, Mohanty SR, Wu J, Michalak TI, Satapathy SK. Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management. World J Hepatol 2018; 10(3): 352-370 |
| URL |
http://www.wjgnet.com/1948-5182/full/v10/i3/352.htm |
| DOI |
http://dx.doi.org/10.4254/wjh.v10.i3.352 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
